Johnson & Johnson is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer. It has more than 250 operating companies conducting business in virtually all countries of the world. Johnson & Johnson’s primary focus has been on products related to human health and well-being. It was incorporated in the State of New Jersey in 1887. The Company’s structure is based on the principle of decentralized management. The Executive Committee of Johnson & Johnson is the principal management group responsible for the operations and allocation of the resources of the Company. Each subsidiary within the business segments is, with some exceptions, managed by citizens of the country where it is located. Johnson & Johnson is organized into three business segments: Consumer, Pharmaceutical and Medical Devices and Diagnostics. The Pharmaceutical segment includes products in the following therapeutic areas: anti-fungal, anti-infective, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, psychotropic (central nervous system), urology and virology. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use by the general public. During the fiscal third quarter of 2011, the Company acquired several over-the-counter cough and cold brands in Russia from J.B. Chemicals and Pharmaceuticals Ltd.

Acquired Companies: 3-Dimensional Pharmaceuticals Inc., ALZA Corporation, OraPharma, Inc., Scios Inc., TransForm Pharmaceuticals Inc., Cordis Corporation, Animas, Crucell N.V., Conor Medsystems Inc., Lifescan, Inc., Cougar Biotechnology Inc., VIRCO, Omrix Biopharmaceuticals, Inc., Tibotec, Ethicon, Mentor Corporation